{
  "id": [
    "29378547"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "29378547"
  ],
  "pmcid": [
    "PMC5789676"
  ],
  "doi": [
    "10.1186/s12888-018-1594-1"
  ],
  "title": [
    "The Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations, Outcomes (REACH-OUT) study: real-world clinical practice in schizophrenia."
  ],
  "authorString": [
    "Joshi K, Mao L, Biondi DM, Millet R."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Joshi K"
          ],
          "firstName": [
            "Kruti"
          ],
          "lastName": [
            "Joshi"
          ],
          "initials": [
            "K"
          ],
          "affiliation": [
            "Janssen Scientific Affairs, LLC, 1125 Trenton-Harbourton Road, Titusville, NJ, 08560, USA. Kjoshi33@its.jnj.com."
          ]
        },
        {
          "fullName": [
            "Mao L"
          ],
          "firstName": [
            "Lian"
          ],
          "lastName": [
            "Mao"
          ],
          "initials": [
            "L"
          ],
          "affiliation": [
            "Janssen Research and Development, LLC, Titusville, NJ, USA."
          ]
        },
        {
          "fullName": [
            "Biondi DM"
          ],
          "firstName": [
            "David M"
          ],
          "lastName": [
            "Biondi"
          ],
          "initials": [
            "DM"
          ],
          "affiliation": [
            "Janssen Scientific Affairs, LLC, 1125 Trenton-Harbourton Road, Titusville, NJ, 08560, USA."
          ]
        },
        {
          "fullName": [
            "Millet R"
          ],
          "firstName": [
            "Robert"
          ],
          "lastName": [
            "Millet"
          ],
          "initials": [
            "R"
          ],
          "affiliation": [
            "Carolina Behavioral Care, Durham, NC, USA."
          ]
        }
      ]
    }
  ],
  "journalInfo": [
    {
      "issue": [
        "1"
      ],
      "volume": [
        "18"
      ],
      "journalIssueId": [
        "2635642"
      ],
      "dateOfPublication": [
        "2018 Jan"
      ],
      "monthOfPublication": [
        "1"
      ],
      "yearOfPublication": [
        "2018"
      ],
      "printPublicationDate": [
        "2018-01-01"
      ],
      "journal": [
        {
          "title": [
            "BMC psychiatry"
          ],
          "ISOAbbreviation": [
            "BMC Psychiatry"
          ],
          "medlineAbbreviation": [
            "BMC Psychiatry"
          ],
          "NLMid": [
            "100968559"
          ],
          "ISSN": [
            "1471-244X"
          ],
          "ESSN": [
            "1471-244X"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2018"
  ],
  "pageInfo": [
    "24"
  ],
  "abstractText": [
    "Outpatient facilities, such as community behavioral health organizations (CBHOs), play a critical role in the care of patients with serious mental illness, but there is a paucity of \"real-world\" patient outcomes data from this health care setting. Therefore, we conducted The Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations, Outcomes (REACH-OUT) trial, a real-world, prospective, noninterventional observational study of patients with mental illness treated at CBHOs across the United States. We describe demographic and clinical characteristics, antipsychotic therapy (APT) treatment patterns, and health care resource utilization in patients with schizophrenia undergoing medical care as usual.This study enrolled adults with schizophrenia or bipolar I disorder who initiated APT treatment at various time points: 1) within 8 weeks of initiating risperidone long-acting injectables (RLAIs) or other APTs except paliperidone palmitate (PP), 2) after more than 24 weeks of continuous RLAI treatment, or 3) at any time after initiating PP LAI treatment (schizophrenia only). Study assessments were performed via participant interview, medical chart abstraction, and clinical survey at enrollment and at month 12.A total of 1065 patients from 46 CBHOs were enrolled. Of these, 944 (88.6%) had a diagnosis of schizophrenia and 121 (11.4%) had bipolar I disorder. At enrollment, 599 (63.5%) of patients with schizophrenia were receiving RLAIs or PP LAI, 281 (29.8%) were receiving oral APTs, and 64 (6.8%) were receiving other injectable APTs. A number of differences in patient characteristics and outcomes were observed between patients in the LAI APT cohort and the oral APT cohort.Descriptive analyses from this observational study suggest differences in the patient characteristics, treatment patterns, and clinical and economic outcomes among those with schizophrenia treated at CBHOs with LAI APT or oral APTs. Additional analyses will be conducted to delineate the impact of LAI APT versus oral APTs on patient outcomes.Clinical Trial Registry: NCT01181960 . Registered 12 August 2010."
  ],
  "affiliation": [
    "Janssen Scientific Affairs, LLC, 1125 Trenton-Harbourton Road, Titusville, NJ, 08560, USA. Kjoshi33@its.jnj.com."
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Electronic"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "Research Support, Non-U.S. Gov't",
        "research-article",
        "Journal Article",
        "Observational Study"
      ]
    }
  ],
  "meshHeadingList": [
    {
      "meshHeading": [
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Humans"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Risperidone"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "TU"
                  ],
                  "qualifierName": [
                    "therapeutic use"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Antipsychotic Agents"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "TU"
                  ],
                  "qualifierName": [
                    "therapeutic use"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Delayed-Action Preparations"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Ambulatory Care"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "MT"
                  ],
                  "qualifierName": [
                    "methods"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "UT"
                  ],
                  "qualifierName": [
                    "utilization"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "SN"
                  ],
                  "qualifierName": [
                    "statistics & numerical data"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Administration, Oral"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Injections"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Follow-Up Studies"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Prospective Studies"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Bipolar Disorder"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DT"
                  ],
                  "qualifierName": [
                    "drug therapy"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Schizophrenia"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DT"
                  ],
                  "qualifierName": [
                    "drug therapy"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Community Mental Health Services"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "MT"
                  ],
                  "qualifierName": [
                    "methods"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "UT"
                  ],
                  "qualifierName": [
                    "utilization"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "SN"
                  ],
                  "qualifierName": [
                    "statistics & numerical data"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Adult"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Middle Aged"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "United States"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Female"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Male"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Practice Patterns, Physicians'"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "SN"
                  ],
                  "qualifierName": [
                    "statistics & numerical data"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Paliperidone Palmitate"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "TU"
                  ],
                  "qualifierName": [
                    "therapeutic use"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        }
      ]
    }
  ],
  "keywordList": [
    {
      "keyword": [
        "Schizophrenia",
        "Observational Study",
        "Paliperidone Palmitate",
        "Real World",
        "Patient Outcomes",
        "Long-acting Injectable",
        "Risperidone Long-acting Injectable",
        "Antipsychotic Therapy",
        "Community Behavioral Health Organizations"
      ]
    }
  ],
  "chemicalList": [
    {
      "chemical": [
        {
          "name": [
            "Delayed-Action Preparations"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Antipsychotic Agents"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "paliperidone palmitate"
          ],
          "registryNumber": [
            "R8P8USM8FR"
          ]
        },
        {
          "name": [
            "Risperidone"
          ],
          "registryNumber": [
            "L6UH7ZF8HC"
          ]
        }
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "http://europepmc.org/articles/PMC5789676?pdf=render"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "http://europepmc.org/articles/PMC5789676"
          ]
        },
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.1186/s12888-018-1594-1"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "Y"
  ],
  "citedByCount": [
    "0"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "Y"
  ],
  "license": [
    "cc by"
  ],
  "authMan": [
    "N"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "nihAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "Y"
  ],
  "tmAccessionTypeList": [
    {
      "accessionType": [
        "nct"
      ]
    }
  ],
  "dateOfCompletion": [
    "2018-07-16"
  ],
  "dateOfCreation": [
    "2018-01-31"
  ],
  "dateOfRevision": [
    "2018-07-16"
  ],
  "electronicPublicationDate": [
    "2018-01-29"
  ],
  "firstPublicationDate": [
    "2018-01-29"
  ]
}